Chitosan is a derivative of chitin that is one of the most abundant biopolymers in nature, found in crustacean shells as well as in fungi cell walls. Most of the commercially available chitosans are produced from the exoskeletons of crustaceans. The extraction process involves harsh chemicals, has limited potential due to the seasonal and limited supply and could cause allergic reactions. However, chitosan has been shown to alleviate the negative effect of environmental stressors in plants, but there is sparse evidence of how chitosan source affects this bioactivity. The aim of this study was to investigate the ability of chitosan from mushroom in comparison to crustacean chitosan in enhancing drought stress tolerance in tomato plants (cv. MicroTom). Chitosan treatment was applied through foliar application and plants were exposed to two 14-day drought stress periods at vegetative and fruit set growth stages. Phenotypic (e.g., fruit number and weight), physiological (RWC) and biochemical-stress-related markers (osmolytes, photosynthetic pigments and malondialdehyde) were analyzed at different time points during the crop growth cycle. Our hypothesis was that this drought stress model will negatively impact tomato plants while the foliar application of chitosan extracted from either crustacean or mushroom will alleviate this effect. Our findings indicate that drought stress markedly decreased the leaf relative water content (RWC) and chlorophyll content, increased lipid peroxidation, and significantly reduced the average fruit number. Chitosan application, regardless of the source, improved these parameters and enhanced plant tolerance to drought stress. It provides a comparative study of the biostimulant activity of chitosan from diverse sources and suggests that chitosan sourced from fungi could serve as a more sustainable and environmentally friendly alternative to the current chitosan from crustaceans.
It is generally accepted that mineral deficiencies, including magnesium and calcium, are widespread globally. Dietary supplementation may be an effective approach to combat such deficiencies. However, challenges associated with limited mineral solubility in the digestive system can impede effective dissolution and hinder absorption, leading to deficiency, and undesirable gastrointestinal disturbances including diarrhoea. Seawater is considered to be a rich source of bioactive magnesium, calcium, and 72 other trace minerals. In this study, we examine two different marine-derived multimineral products as potential dietary supplements. Aquamin-Mg, sourced from seawater is rich in magnesium (12%), and Aquamin F, a seaweed-derived multimineral is rich in calcium (32%). Both products also contain a diverse array of over 72 minerals, characteristic of their oceanic origin. Our study comprises two experiments. The first experiment evaluates and compares the solubility of Aquamin-Mg, commercially available magnesium bisglycinate, and Pure Magnesium Bisglycinate (PrizMAG) during in vitro digestion using the INFOGEST method. Results demonstrate that Aquamin-Mg exhibits superior solubility than the other magnesium sources during the gastric and intestinal phases, particularly when administered alongside food materials. The second experiment is a randomized, double-blind, placebo-controlled study in a small cohort of healthy older aged adults to assess the tolerability of a combined Aquamin-Mg/Aquamin-F supplement over a 12-week period. The findings indicate that this combination supplement is well-tolerated, with no significant adverse events reported, emphasizing its potential as a means of addressing mineral deficiencies.
Background: An increase in plant-sourced (PS) nutrient intake is promoted in support of a sustainable diet. PS dietary minerals and proteins have bioactive properties that can affect bone health and the risk of fracture. Methods: In a group randomised, cross-over design, this study evaluated the post-ingestion temporal pattern of change in arterialised ionised calcium (iCa), parathyroid hormone (PTH), C-terminal crosslinked telopeptide of type I collagen (CTX) and procollagen type 1 amino-terminal propeptide (P1NP) for 4 h following ingestion of a novel supplement (SUPP) containing a PS marine multi-mineral + PS protein isolate. A diurnally matched intake of mineral water was used as a control (CON). Results: Compared to baseline, the change in iCa concentration was 0.022 (95% CI, 0.006 to 0.038, p = 0.011) mmol/l greater in SUPP than CON, resulting in a −4.214 (95% CI, −8.244 to −0.183, p = 0.042) pg/mL mean reduction in PTH, a −0.64 (95% CI, −0.199 to −0.008, p = 0.029) ng/mL decrease in the biomarker of bone resorption, CTX, and no change in the biomarker of bone formation, P1NP. Conclusions: When used as a dietary supplement, or incorporated into a food matrix, the promotion of PS marine multi-mineral and PS protein isolates may contribute to a more sustainable diet and overall bone health.
10 July 2026 in Biocatalysis and Agricultural Biotechnology
Background/Objectives: Magnesium (Mg2+) supplements can contain different types of Mg2+ salts, which influence their bioavailability. A highly bioavailable and bioaccessible Mg2+ source is essential to meet requirements for many physiological processes that are fundamental to human health. The objective of this study was to compare the bioavailability of Mg2+ from different sources, with different composition and chemical structure, namely, Aquamin Mg Soluble (seawater), magnesium oxide, commercial magnesium bisglycinate 1, and analytical grade magnesium bisglycinate 2. In addition, the influence of the different Mg2+ sources on transported Mg2+ and expression of TRPM6 and TRPM7 genes in Caco-2 cell monolayers was also evaluated to estimate bioavailability. TRPM6 and TRPM7 are members of the transient receptor potential melastatin subfamily characterized as Mg2+ permeable channels. Method: The study involved analyzing bioavailability of the Mg2+ sources predigested with and without food using the Infogest model prior to application to a Caco-2 cell monolayer in transwells for assessing transport. Mg2+ concentration on the basolateral side was analyzed by ICP-MS, and expression of TRPM6 and TRPM7 genes in the monolayer was analyzed using real-time qPCR. Results: Aquamin Mg Soluble showed significantly higher bioavailability compared to magnesium bisglycinate 2 (p = 0.016) when digested with food prior to application to the Caco-2 monolayer. In the digestion without food prior to the Caco-2 monolayer, there was no significant difference between Mg2+ bioavailability among the tested supplements. The TRPM6 gene was significantly downregulated in Caco-2 monolayers exposed to Aquamin Mg Soluble compared to untreated Caco-2 cells (p < 0.001). Conclusions: The INFOGEST digestion model showed that Aquamin Mg Soluble provides a highly bioavailable form of Mg2+, while the Caco-2 monolayer model also demonstrated its increased bioavailability by the modulation of TRPM6 gene expression.